AcelRx Pharmaceuticals PE Ratio 2009-2018 | ACRX

Current and historical p/e ratio for AcelRx Pharmaceuticals (ACRX) from 2009 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. AcelRx Pharmaceuticals PE ratio as of January 22, 2019 is 0.00.
AcelRx Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-01-23 2.48 0.00
2018-09-30 3.85 $-0.84 0.00
2018-06-30 3.38 $-0.91 0.00
2018-03-31 2.10 $-1.00 0.00
2017-12-31 2.03 $-1.11 0.00
2017-09-30 4.60 $-1.12 0.00
2017-06-30 2.15 $-1.09 0.00
2017-03-31 3.15 $-1.04 0.00
2016-12-31 2.60 $-0.95 0.00
2016-09-30 3.89 $-0.98 0.00
2016-06-30 2.69 $-0.62 0.00
2016-03-31 3.08 $-0.58 0.00
2015-12-31 3.85 $-0.60 0.00
2015-09-30 3.05 $-0.68 0.00
2015-06-30 4.24 $-0.92 0.00
2015-03-31 3.86 $-1.02 0.00
2014-12-31 6.73 $-0.97 0.00
2014-09-30 5.49 $-0.24 0.00
2014-06-30 10.25 $-0.37 0.00
2014-03-31 12.01 $-0.54 0.00
2013-12-31 11.31 $-0.66 0.00
2013-09-30 10.78 $-1.48 0.00
2013-06-30 9.27 $-1.60 0.00
2013-03-31 5.16 $-1.48 0.00
2012-12-31 4.26 $-1.50 0.00
2012-09-30 3.19 $-1.42 0.00
2012-06-30 3.25 $-1.34 0.00
2012-03-31 3.49 $-1.24 0.00
2011-12-31 1.92 $-1.18 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.157B $0.008B
AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the Sufentanil NanoTab PCA System; ARX-02 or the Sufentanil NanoTab BTP Management System; and ARX-03 or the Sufentanil/Triazolam NanoTab which are in their development stage. Its product ARX-01 is focused on acute post-operative pain, ARX-02 is focused on the treatment of cancer breakthrough pain and ARX-03 is focused on providing mild sedation, anxiety reduction, and pain relief to patients undergoing painful procedures in a physician's office. AcelRx Pharmaceuticals, Inc. is headquartered in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $40.401B 27.66
Takeda Pharmaceutical (TAK) Japan $31.388B 14.66
Grifols (GRFS) Spain $13.119B 15.90
Neurocrine Biosciences (NBIX) United States $8.277B 1825.60
Ionis Pharmaceuticals (IONS) United States $7.902B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.761B 11.14
Nektar Therapeutics (NKTR) United States $7.747B 11.11
Loxo Oncology (LOXO) United States $7.157B 0.00
Tilray (TLRY) United States $6.782B 0.00
Sage Therapeutics (SAGE) United States $6.437B 0.00
Catalent (CTLT) United States $5.145B 21.58
United Therapeutics (UTHR) United States $4.965B 8.12
FibroGen (FGEN) United States $4.370B 0.00
TESARO (TSRO) United States $4.126B 0.00
Impax Laboratories (AMRX) United States $3.714B 19.75
Taro Pharmaceutical Industries (TARO) Israel $3.632B 13.45
USANA Health Sciences (USNA) United States $2.770B 23.58
Endo (ENDP) Ireland $2.084B 3.19
Heron Therapeutics (HRTX) United States $2.047B 0.00
Aerie Pharmaceuticals (AERI) United States $2.000B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.960B 0.00
Xencor (XNCR) United States $1.848B 0.00
Zogenix (ZGNX) United States $1.779B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.751B 0.00
Portola Pharmaceuticals (PTLA) United States $1.696B 0.00
Corcept Therapeutics (CORT) United States $1.695B 24.88
PTC Therapeutics (PTCT) United States $1.666B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.663B 224.78
Enanta Pharmaceuticals (ENTA) United States $1.495B 21.02
Theravance Biopharma (TBPH) Cayman Islands $1.472B 0.00
TherapeuticsMD (TXMD) United States $1.223B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.208B 0.00
Esperion Therapeutics (ESPR) United States $1.126B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.126B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.979B 0.00
Tricida (TCDA) United States $0.940B 0.00
Radius Health (RDUS) United States $0.759B 0.00
ImmunoGen (IMGN) United States $0.735B 0.00
ChemoCentryx (CCXI) United States $0.592B 46.84
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.588B 0.00
Siga Technologies (SIGA) United States $0.569B 0.00
Karyopharm Therapeutics (KPTI) United States $0.556B 0.00
Flexion Therapeutics (FLXN) United States $0.524B 0.00
Collegium Pharmaceutical (COLL) United States $0.509B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.506B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.465B 27.40
Odonate Therapeutics (ODT) United States $0.454B 0.00
GlycoMimetics (GLYC) United States $0.444B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Forty Seven (FTSV) United States $0.411B 0.00
Aptorum Group (APM) China $0.405B 0.00
ArQule (ARQL) United States $0.392B 0.00
Majesco Entertainment (PTE) United States $0.351B 0.00
Xeris Pharmaceuticals (XERS) United States $0.348B 0.00
Akebia Therapeutics (AKBA) United States $0.344B 0.00
CASI Pharmaceuticals (CASI) United States $0.339B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.337B 0.00
Concert Pharmaceuticals (CNCE) United States $0.335B 0.00
Lannett Co Inc (LCI) United States $0.306B 2.65
KalVista Pharmaceuticals (KALV) United States $0.284B 0.00
OptiNose (OPTN) United States $0.271B 0.00
Tapimmune (MRKR) United States $0.270B 0.00
Minerva Neurosciences (NERV) United States $0.270B 0.00
Dermira (DERM) United States $0.268B 0.00
Depomed (ASRT) United States $0.256B 9.55
Catalyst Pharmaceuticals (CPRX) United States $0.256B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.254B 0.00
IMV INC (IMV) Canada $0.254B 0.00
Aclaris Therapeutics (ACRS) United States $0.252B 0.00
Mast Therapeutics (SVRA) United States $0.251B 0.00
Opexa Therapeutics (ACER) United States $0.241B 0.00
Rafael Holdings (RFL) United States $0.232B 0.00
Tyme Technologies (TYME) United States $0.225B 0.00
Aldeyra Therapeutics (ALDX) United States $0.223B 0.00
Translate Bio (TBIO) United States $0.221B 0.00
Dova Pharmaceuticals (DOVA) United States $0.219B 0.00
Aratana Therapeutics (PETX) United States $0.212B 0.00
Affimed (AFMD) Germany $0.211B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.210B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.200B 0.00
MEI Pharma (MEIP) United States $0.191B 0.00
Galectin Therapeutics (GALT) United States $0.190B 0.00
Aquestive Therapeutics (AQST) United States $0.189B 0.00
Zafgen (ZFGN) United States $0.171B 0.00
Recro Pharma (REPH) United States $0.165B 0.00
ElectroCore (ECOR) United States $0.160B 0.00
Calithera Biosciences (CALA) United States $0.159B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.158B 0.00
Ocular Therapeutix (OCUL) United States $0.155B 0.00
Molecular Templates (MTEM) United States $0.154B 0.00
Redhill Biopharma (RDHL) Israel $0.153B 0.00
Nature's Sunshine Products (NATR) United States $0.151B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.140B 0.00
Adherex Technologies (FENC) United States $0.136B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.133B 0.00
MediWound (MDWD) Israel $0.132B 0.00
Neon Therapeutics (NTGN) United States $0.131B 0.00
Ardelyx (ARDX) United States $0.126B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.124B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.123B 0.00
Jounce Therapeutics (JNCE) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.117B 0.00
Cardiome Pharma (CORV) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.112B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.110B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.109B 0.00
ProNAi Therapeutics (SRRA) Canada $0.105B 0.00
CHINA SXT PHARM (SXTC) China $0.098B 0.00
DURECT (DRRX) United States $0.096B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.092B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.090B 0.00
Natural Alternatives (NAII) United States $0.084B 8.25
Nivalis Therapeutics (ALPN) United States $0.075B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.074B 0.00
KemPharm (KMPH) United States $0.073B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Immune Design (IMDZ) United States $0.068B 0.00
Avenue Therapeutics (ATXI) United States $0.067B 0.00
CTI BioPharma (CTIC) United States $0.066B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
BioLineRx (BLRX) Israel $0.064B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.063B 0.00
Otonomy (OTIC) United States $0.061B 0.00
Neos Therapeutics (NEOS) United States $0.060B 0.00
Achaogen (AKAO) United States $0.059B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.057B 0.00
Melinta Therapeutics (MLNT) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.053B 0.00
Forward Pharma (FWP) Denmark $0.052B 0.00
Genocea Biosciences (GNCA) United States $0.049B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
ContraFect (CFRX) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
NOVAN INC (NOVN) United States $0.039B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Capnia (SLNO) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.032B 0.00
PharmAthene (ALT) United States $0.030B 0.00
ESSA Pharma (EPIX) Canada $0.025B 0.00
IsoRay (ISR) United States $0.025B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.025B 0.00
Trillium Therapeutics (TRIL) Canada $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 0.00
Pain Therapeutics (PTIE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.015B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.013B 0.00
Aviragen Therapeutics (VXRT) United States $0.013B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 1.26
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Onconova Therapeutics (ONTX) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Intellipharmaceutics (IPCI) Canada $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00